ArticleInvestigational new drugs2014

HLA-restricted NY-ESO-1 peptide immunotherapy for metastatic castration resistant prostate cancer.

Guru Sonpavde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.